Five factor model of schizophrenia: Replication across samples

In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Schizophrenia research 1995-02, Vol.14 (3), p.229-234
Hauptverfasser: Lindenmayer, Jean-Pierre, Grochowski, Sandra, Hyman, Ruth B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 234
container_issue 3
container_start_page 229
container_title Schizophrenia research
container_volume 14
creator Lindenmayer, Jean-Pierre
Grochowski, Sandra
Hyman, Ruth B.
description In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drugfree period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS.
doi_str_mv 10.1016/0920-9964(94)00041-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77291284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0920996494000416</els_id><sourcerecordid>77291284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-df409650797b71e0f6f461f55c065bdbcd579abe5c765c2be08c1a7a169113683</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMoc378A4VeiOhFNWnzsXgxkOFUGAii1yFNT1ikbWrSDfTX221ll16di_c557w8CF0QfEcw4fdYZjiVktMbSW8xxpSk_ACNCRN5mjEsD9F4jxyjkxi_eogwLEZoJATnLKdjNJ27NSRWm86HpPYlVIm3STRL9-vbZYDG6YfkHdrKGd053yTaBB9jEnXdVhDP0JHVVYTzYZ6iz_nTx-wlXbw9v84eF6nJuejS0lIsef9aikIQwJZbyollzGDOirIwJRNSF8CM4MxkBeCJIVpowiUhOZ_kp-h6d7cN_nsFsVO1iwaqSjfgV1EJkUmSTWgP0h24rRnAqja4WocfRbDaaFMbJ2rjREmqttoU79cuh_urooZyvzR46vOrIdfR6MoG3RgX91ieSyqk7LHpDoPexdpBUNE4aAyULoDpVOnd_z3-AIlBh_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77291284</pqid></control><display><type>article</type><title>Five factor model of schizophrenia: Replication across samples</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lindenmayer, Jean-Pierre ; Grochowski, Sandra ; Hyman, Ruth B.</creator><creatorcontrib>Lindenmayer, Jean-Pierre ; Grochowski, Sandra ; Hyman, Ruth B.</creatorcontrib><description>In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drugfree period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS.</description><identifier>ISSN: 0920-9964</identifier><identifier>EISSN: 1573-2509</identifier><identifier>DOI: 10.1016/0920-9964(94)00041-6</identifier><identifier>PMID: 7766534</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adult ; Adult and adolescent clinical studies ; Age of Onset ; Biological and medical sciences ; Double-Blind Method ; Factor Analysis, Statistical ; Female ; Humans ; Male ; Medical sciences ; Placebos ; Positive and negative symptoms ; Psychiatric Status Rating Scales ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Reproducibility of Results ; Schizophrenia ; Schizophrenia - diagnosis ; Schizophrenic Psychology</subject><ispartof>Schizophrenia research, 1995-02, Vol.14 (3), p.229-234</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-df409650797b71e0f6f461f55c065bdbcd579abe5c765c2be08c1a7a169113683</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0920-9964(94)00041-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3394799$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7766534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lindenmayer, Jean-Pierre</creatorcontrib><creatorcontrib>Grochowski, Sandra</creatorcontrib><creatorcontrib>Hyman, Ruth B.</creatorcontrib><title>Five factor model of schizophrenia: Replication across samples</title><title>Schizophrenia research</title><addtitle>Schizophr Res</addtitle><description>In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drugfree period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Age of Onset</subject><subject>Biological and medical sciences</subject><subject>Double-Blind Method</subject><subject>Factor Analysis, Statistical</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Placebos</subject><subject>Positive and negative symptoms</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Reproducibility of Results</subject><subject>Schizophrenia</subject><subject>Schizophrenia - diagnosis</subject><subject>Schizophrenic Psychology</subject><issn>0920-9964</issn><issn>1573-2509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1LwzAUhoMoc378A4VeiOhFNWnzsXgxkOFUGAii1yFNT1ikbWrSDfTX221ll16di_c557w8CF0QfEcw4fdYZjiVktMbSW8xxpSk_ACNCRN5mjEsD9F4jxyjkxi_eogwLEZoJATnLKdjNJ27NSRWm86HpPYlVIm3STRL9-vbZYDG6YfkHdrKGd053yTaBB9jEnXdVhDP0JHVVYTzYZ6iz_nTx-wlXbw9v84eF6nJuejS0lIsef9aikIQwJZbyollzGDOirIwJRNSF8CM4MxkBeCJIVpowiUhOZ_kp-h6d7cN_nsFsVO1iwaqSjfgV1EJkUmSTWgP0h24rRnAqja4WocfRbDaaFMbJ2rjREmqttoU79cuh_urooZyvzR46vOrIdfR6MoG3RgX91ieSyqk7LHpDoPexdpBUNE4aAyULoDpVOnd_z3-AIlBh_w</recordid><startdate>199502</startdate><enddate>199502</enddate><creator>Lindenmayer, Jean-Pierre</creator><creator>Grochowski, Sandra</creator><creator>Hyman, Ruth B.</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199502</creationdate><title>Five factor model of schizophrenia: Replication across samples</title><author>Lindenmayer, Jean-Pierre ; Grochowski, Sandra ; Hyman, Ruth B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-df409650797b71e0f6f461f55c065bdbcd579abe5c765c2be08c1a7a169113683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Age of Onset</topic><topic>Biological and medical sciences</topic><topic>Double-Blind Method</topic><topic>Factor Analysis, Statistical</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Placebos</topic><topic>Positive and negative symptoms</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Reproducibility of Results</topic><topic>Schizophrenia</topic><topic>Schizophrenia - diagnosis</topic><topic>Schizophrenic Psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lindenmayer, Jean-Pierre</creatorcontrib><creatorcontrib>Grochowski, Sandra</creatorcontrib><creatorcontrib>Hyman, Ruth B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Schizophrenia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lindenmayer, Jean-Pierre</au><au>Grochowski, Sandra</au><au>Hyman, Ruth B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Five factor model of schizophrenia: Replication across samples</atitle><jtitle>Schizophrenia research</jtitle><addtitle>Schizophr Res</addtitle><date>1995-02</date><risdate>1995</risdate><volume>14</volume><issue>3</issue><spage>229</spage><epage>234</epage><pages>229-234</pages><issn>0920-9964</issn><eissn>1573-2509</eissn><abstract>In order to examine the effect of neuroleptic medication on the factor structure of schizophrenic symptomatology, 517 DSM-III-R schizophrenic in-patients enrolled in a multicenter phase II drug study were evaluated on their pre-existing neuroleptic at screening on the Positive and Negative Syndrome Scale (PANSS) and after a one-week drugfree period. Separate principal components analyses of the PANSS were done at each time point. PANSS total and component scores were assessed for differences utilizing paired t-tests. Both factor analyses confirmed the five factor model (negative, positive, cognitive, excitement and depression components) explaining 51.7 and 56.2% of the variances at each time point. After medication wash-out psychopathology significantly worsened as measured by total PANSS score and by each of the components. The overall worsening of component scores appeared global and uniform, as evidenced by the fact that at washout, the proportion of individual component scores to total psychopathology remained constant for most components. The lack of change of most components in proportion to the psychopathology total is evidence for the stability of these individual psychopathological dimensions of patients while on and off neuroleptics. The results further support the validity of the five-factor model of schizophrenic psychopathology as measured by the PANSS.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>7766534</pmid><doi>10.1016/0920-9964(94)00041-6</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0920-9964
ispartof Schizophrenia research, 1995-02, Vol.14 (3), p.229-234
issn 0920-9964
1573-2509
language eng
recordid cdi_proquest_miscellaneous_77291284
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Adult and adolescent clinical studies
Age of Onset
Biological and medical sciences
Double-Blind Method
Factor Analysis, Statistical
Female
Humans
Male
Medical sciences
Placebos
Positive and negative symptoms
Psychiatric Status Rating Scales
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Reproducibility of Results
Schizophrenia
Schizophrenia - diagnosis
Schizophrenic Psychology
title Five factor model of schizophrenia: Replication across samples
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A59%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Five%20factor%20model%20of%20schizophrenia:%20Replication%20across%20samples&rft.jtitle=Schizophrenia%20research&rft.au=Lindenmayer,%20Jean-Pierre&rft.date=1995-02&rft.volume=14&rft.issue=3&rft.spage=229&rft.epage=234&rft.pages=229-234&rft.issn=0920-9964&rft.eissn=1573-2509&rft_id=info:doi/10.1016/0920-9964(94)00041-6&rft_dat=%3Cproquest_cross%3E77291284%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77291284&rft_id=info:pmid/7766534&rft_els_id=0920996494000416&rfr_iscdi=true